BridgeMD
New treatment option for Breastfeeding, Exclusive
Official title Synergistic Activity of Human Milk Nutrients and Infant Cognition
ClinicalTrials.gov ID: NCT03838536
What this study is testing
- What it's testing
- Purpose: To establish a whole food, egg, as a viable study material to supplement mothers and infants with nutrients that support optimal brain development. There will be 84 breastfeeding dyads, 3 months postnatal.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 35. Healthy volunteers may be eligible.
You may be able to join if
- infant is 12-15 weeks of age at enrollment
- healthy, lactating mother age 18-35
- gave birth at \>38 weeks gestation without remarkable incident
- consuming \<=50% of the recommended amounts of 2 of the 3, DHA, choline, and lutein
You likely can't join if
- infant with diagnosis or documented suspicion of developmental delay
- egg allergy or family history of egg allergy
- gestational diabetes
- any documented seizure activity
The study team makes the final eligibility decision.
Where it's taking place
- Kannapolis, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 months to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kannapolis, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.